StockData

Syra Health Corp (SYRA) stock

SYRAOTCServices-Employment AgenciesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$0.83−0.03 (-3.98%)

Close on Oct 19, 2026Market cap $11.19MP/E 82.6Yield –

Syra Health r&d expenses

Research and development expenses are spending on new products and technology.

Syra Health's R&D Expenses for the twelve months ending Jun 30, 2026 was $55.23K. For fiscal 2025 it was $67.84K, down 88.4% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$67.84K-88.4%
FY2024Dec 31, 2024$585.15K+143.8%
FY2023Dec 31, 2023$240.05K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$47.35K+59.4%
Q1 FY2026Mar 31, 2026$6.92K-81.4%
Q4 FY2025Dec 31, 2025$139-99.6%
Q3 FY2025Sep 30, 2025$816-99.7%
Q2 FY2025Jun 30, 2025$29.71K-89.3%
Q1 FY2025Mar 31, 2025$37.17K–
Q3 FY2024Sep 30, 2024$34.82K–
Q2 FY2024Jun 30, 2024$277.89K–
Q1 FY2024Mar 31, 2024$277.55K–

More Syra Health figures

See a number that looks wrong?